866-997-4948(US-Canada Toll Free)

Investigation Report on China ribonucleic acid II (RNAII) for Injection, 2010-2019

Published By :

China Research and Intelligence Co., Ltd. (CRI)

Published Date : Jul 2015

Category :

Manufacturing, Packaging & Detailing

No. of Pages : 30 Pages


RNAII for injection, one kind of immunomodulator, can improve body immunity and inhibit tumor by causing vacuolar degeneration and colliquative necrosis in tumor cells as well as generating large amounts of hyperplastic fibroblasts, macrophages, lymphocytes or even connective tissue to substitute tumor tissue. And it is used for the adjuvant treatment of pancreatic cancer, liver cancer, stomach cancer, breast cancer, soft tissue sarcoma and other cancers especially hepatitis B. RNAII for injection can also be used for the treatment of various diseases caused by low immune function.

According to CRI’s market survey, RNAII for injection develops fast in China with sales value rising from less than CNY 60 million in 2005 to about CNY 500 million in 2014 and CAGR during this period reaching 80%.

With the lifestyle changes brought about by economic development as well as the serious environmental pollution, the incidence of cancer keeps increasing with the number of new cases exceeding 3 million each year in China. Meanwhile, there are over 90 million hepatitis B patients in China too. Therefore, the market size of RNAII for injection is expected to keep growing in the next few years in China.

Readers can get at least the following information from this report:
  • market size of RNAII for injection in China
  • competitive landscape of RNAII for injection in Chinese market
  • price of RNAII for injection made by different enterprises in China
  • market outlook of RNAII for injection in China
suggests the following groups of people purchase this report:
  • manufacturers of immunomodulator
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

1 Related Concepts of RNAII for Injection
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of RNAII for Injection in China
2.1 Patent and Approval Status of RNAII for Injection in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of RNAII for Injection in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of RNAII for Injection in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of RNAII for Injection in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of RNAII for Injection in Chinese Hospitals in 2014
6.1 Jilin Aodong Pharmaceutical Industry Group Yanji Co., Ltd
6.2 Nanjing Xinbai Pharmaceutical Co., Ltd
6.3 Xinxiang Dongsheng Pharmaceutical Co., Ltd

7 Major Manufacturers of RNAII for Injection in Chinese Market, 2010-2014
7.1 Jilin Aodong Pharmaceutical Industry Group Yanji Co., Ltd
7.2 Nanjing Xinbai Pharmaceutical Co., Ltd
7.3 Xinxiang Dongsheng Pharmaceutical Co., Ltd

8 Market Outlook of RNAII for Injection in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Chart


Chart Approval Information of RNAII for Injection in China
Chart Sales Status of RNAII for Injection in China
Chart Sales Value of RNAII for Injection in China, 2010-2014
Chart Sales Value of RNAII for Injection in Some Regions in China, 2010-2014
Chart Sales Volume of RNAII for Injection in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of RNAII for Injection for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of RNAII for Injection Made by Jilin Aodong Pharmaceutical Industry Group Yanji Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of RNAII for Injection Made by Nanjing Xinbai Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of RNAII for Injection Made by Xinxiang Dongsheng Pharmaceutical Co., Ltd in China, 2010-2014
Chart Price of RNAII for Injection Made by Jilin Aodong Pharmaceutical Industry Group Yanji Co., Ltd in Some Chinese Cities in 2014
Chart Price of RNAII for Injection Made by Nanjing Xinbai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of RNAII for Injection Made by Xinxiang Dongsheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *